BioMarin Pharmaceutical Inc
Price
FilingsNewest: 8-K, Material agreementSep 30 →InsidersNo open-market buys. 3 insiders sold $3.2M, 0 of 4 sales on a 10b5-1 plan.→HoldersBlackRock 10.6%Dodge & Cox 7.7%Primecap Management Co/ca/ 7.3%→PeersClosest companies: MIRM, TVTX, NUVB→
From the filings
Figures
- Revenue
- $3.41Blast 12 months
- Net income
- $73.0Mlast 12 months
- Operating cash flow
- $874.3Mlast 12 months
- Cash and equivalents
- $874.0Mat the last balance sheet
- Total debt
- $4.19Bat the last balance sheet
- Shares outstanding
- 193.5M shareson issue